EC awards grant to commercialise Latima ’s cancer virotherapy medicine

The European Commission (EC) has awarded a grant to Latima to commercialise its cancer virotherapy medicine in the European Union (EU) markets.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news